• Vedolizumab Studies: Long-Term Safety and a Post Hoc Analysis of VARSITY

    Vedolizumab Studies: Long-Term Safety and a Post Hoc Analysis of VARSITY
    Originally published by our sister publication Gastroenterology & Endoscopy NewsMiguel Regueiro, MDProfessor of MedicineChief of the Digestive Disease InstituteCleveland ClinicCleveland, OhioCourtesy of Miguel RegueiroBy Miguel Regueiro, MD, with Marcus A. BanksThe first study in this edition of The Regueiro Report is a post-market long-term analysis of the safety and efficacy of vedolizumab to treat ulcerative colitis and Crohn’s disease.The total dataset included more than 5,000 patients
  • Why Human Oversight Is Essential in a Tech-Heavy Sterile Compounding Era

    Why Human Oversight Is Essential in a Tech-Heavy Sterile Compounding Era
    By Annie Lambert, PharmD, BCSCPSterile compounding remains a cornerstone of medication management, particularly during drug shortages or when patients require customized therapies. At the same time, hospital and health-system pharmacies continue to face staffing pressures and increasingly complex medication needs. To improve efficiency and consistency, many programs have turned to assistive technologies that streamline compounding workflows.As compounding becomes more automated, distributed, and

Follow @newsl_pharmacy on Twitter!